SEOUL -- South Korea's Celltrion has started selling coronavirus screening kits in the U.S. to help bridge the country's testing gap, the company said Wednesday.
The Incheon-based drugmaker expects both its antigen and antibody testing kits to be approved for sale in the U.S. by mid-August. A U.S. subsidiary will distribute the kits.
